Jutta Bergler-Klein Selected Research

Jutta Bergler-Klein Research Topics

Disease

15	Heart Failure 12/2023 - 01/2004
13	Neoplasms (Cancer) 05/2024 - 08/2013
12	Aortic Valve Stenosis (Aortic Stenosis) 11/2021 - 05/2004
11	Cardiotoxicity 05/2024 - 08/2013
9	Atrial Fibrillation 01/2024 - 07/2007
7	Stroke (Strokes) 01/2024 - 04/2015
6	Inflammation (Inflammations) 10/2022 - 03/2012
4	Myocardial Infarction 01/2024 - 04/2015
4	Fibrosis (Cirrhosis) 04/2023 - 08/2016
4	Cardiovascular Diseases (Cardiovascular Disease) 10/2022 - 05/2011
4	Coronary Artery Disease (Coronary Atherosclerosis) 10/2022 - 05/2004
3	Hemorrhage 01/2024 - 10/2020
2	Multiple Myeloma 05/2024 - 11/2020
2	Cardiomyopathies (Cardiomyopathy) 08/2023 - 01/2020
2	Breast Neoplasms (Breast Cancer) 01/2021 - 12/2019
2	Heart Valve Diseases (Valvular Heart Disease) 11/2017 - 09/2014
2	Myocardial Ischemia (Ischemic Heart Diseases) 04/2015 - 10/2014
2	Mitral Valve Insufficiency (Mitral Regurgitation) 02/2011 - 07/2007
1	Hematologic Neoplasms (Hematological Malignancy) 05/2024
1	Amyloidosis 01/2024
1	Chronic Renal Insufficiency 01/2024
1	Embolism (Embolus) 01/2024
1	Pericardial Effusion 12/2023
1	Second Primary Neoplasms (Neoplasms, Second) 12/2023
1	Fatigue 09/2023
1	Post-Acute COVID-19 Syndrome 09/2023
1	Transthyretin-Related Hereditary Amyloidosis 08/2023
1	Heart Diseases (Heart Disease) 10/2022
1	Dizziness (Lightheadedness) 10/2021
1	Pruritus (Itching) 10/2021
1	Body Weight (Weight, Body) 01/2020
1	Hypertension (High Blood Pressure) 04/2019

Drug/Important Bio-Agent (IBA)

10	Biomarkers (Surrogate Marker)IBA 10/2022 - 05/2011
7	AnthracyclinesIBA 05/2024 - 09/2015
7	Brain Natriuretic Peptide (Natrecor)FDA Link 01/2020 - 06/2007
6	Natriuretic PeptidesIBA 11/2020 - 05/2004
4	Dabigatran FDA Link 01/2024 - 01/2020
4	Dobutamine FDA LinkGeneric 11/2021 - 09/2008
3	Vitamin K FDA Link 01/2024 - 01/2020
3	Angiotensin-Converting Enzyme Inhibitors (ACE Inhibitors)IBA 04/2023 - 01/2004
3	pro-brain natriuretic peptide (1-76)IBA 05/2011 - 03/2009
2	Phosphotransferases (Kinase)IBA 05/2024 - 11/2020
2	Immune Checkpoint InhibitorsIBA 05/2024 - 09/2022
2	Amyloid (Amyloid Fibrils)IBA 01/2024 - 08/2023
2	MicroRNAs (MicroRNA)IBA 11/2023 - 01/2018
2	Doxorubicin (Adriamycin)FDA LinkGeneric 11/2023 - 04/2023
2	RNA (Ribonucleic Acid)IBA 08/2023 - 04/2023
2	C-Reactive ProteinIBA 10/2022 - 11/2017
2	AnticoagulantsIBA 11/2021 - 01/2020
2	TroponinIBA 11/2020 - 01/2018
2	Trastuzumab (Herceptin)FDA Link 11/2020 - 11/2020
1	bcr-abl Fusion ProteinsIBA 05/2024
1	Anti-Inflammatory Agents (Anti-Inflammatories)IBA 01/2024
1	Platelet Aggregation Inhibitors (Antiplatelet Drugs)IBA 01/2024
1	Factor Xa (Coagulation Factor Xa)IBA 01/2024
1	Non-Steroidal Anti-Inflammatory Agents (NSAIDs)IBA 12/2023
1	Messenger RNA (mRNA)IBA 11/2023
1	Circular RNAIBA 11/2023
1	Immunoglobulin G (IgG)IBA 09/2023
1	Immunoglobulin M (IgM)IBA 09/2023
1	A-factor (Streptomyces)IBA 09/2023
1	COVID-19 VaccinesIBA 09/2023
1	InotersenIBA 08/2023
1	patisiranIBA 08/2023
1	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 04/2023
1	DiureticsIBA 04/2023
1	AngiotensinsIBA 09/2022
1	Enalapril FDA LinkGeneric 10/2021
1	sacubitril and valsartan sodium hydrate drug combinationIBA 10/2021
1	Proteasome InhibitorsIBA 11/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 11/2020
1	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 11/2020
1	AndrogensIBA 11/2020
1	Immunomodulating AgentsIBA 11/2020
1	GadoliniumIBA 01/2020
1	InterferonsIBA 01/2020
1	Interleukin-1 (Interleukin 1)IBA 01/2020
1	CollagenIBA 01/2020
1	Calcium-Binding ProteinsIBA 01/2020
1	Lipocalin-2IBA 01/2020
1	Troponin IIBA 01/2020
1	ischemia-modified albuminIBA 01/2020
1	liposomal doxorubicin (Doxil)FDA Link 01/2020
1	AdrenomedullinIBA 01/2020
1	Urokinase Plasminogen Activator ReceptorsIBA 01/2020
1	Antineoplastic Agents (Antineoplastics)IBA 12/2018
1	von Willebrand FactorIBA 01/2018
1	Lipoprotein(a)IBA 01/2018

Therapy/Procedure

17	Therapeutics 05/2024 - 09/2012
5	Drug Therapy (Chemotherapy) 11/2020 - 12/2003
2	Percutaneous Coronary Intervention 10/2022 - 12/2014
2	Radiotherapy 09/2022 - 12/2019
2	Transcatheter Aortic Valve Replacement 12/2020 - 01/2018
2	Conservative Treatment 12/2020 - 09/2008
2	Cell- and Tissue-Based Therapy (Cell Therapy) 04/2015 - 10/2014
2	Radiofrequency Ablation 03/2012 - 10/2011
1	Hematopoietic Stem Cell Transplantation 05/2024
1	RNAi Therapeutics 08/2023
1	Aftercare (After-Treatment) 12/2019
1	Immunotherapy 12/2019